December 06, 2024 13 min read Microbial keratitis is a diverse and changing landscape. The type and prevalence of pathogens vary according to location and climate, while human mobility and global warming, with their multiple implications, are bringing unforeseen changes and new phenomena. Antimicrobial resistance, with the rise of aggressive organisms that do not … [Read more...] about Specialists address challenges of microbial keratitis management
News
Recurrent erosions after PRK can be treated with anti-inflammatory protocol
December 06, 2024 2 min read A small percentage of patients who had PRK may have recurrent erosions postoperatively. In most patients, these erosions resolve on their own as the epithelium recovers and adheres to the cornea. But in some patients, recurrent erosions may persist. It can be frustrating, especially when the vision outcome is great. Typically, we would … [Read more...] about Recurrent erosions after PRK can be treated with anti-inflammatory protocol
Older man experiences sudden painless vision loss
December 06, 2024 6 min read A 70-year-old man presented for an urgent visit to the retina clinic for sudden painless vision loss of his right eye. The patient had a history of hypertension, hyperlipidemia, obesity, obstructive sleep apnea, coronary artery disease status post quadruple bypass and type 2 diabetes. Notably, he had been followed for mild to moderate … [Read more...] about Older man experiences sudden painless vision loss
Part 5: Advice from the experts: Helpful information for current residents
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.Video Transcript:Editor's note: The below transcript has been lightly edited for clarity.Alfredo Sadun, MD, PhD:Well, first of all, I should say, for full disclosure, I was the residency program director … [Read more...] about Part 5: Advice from the experts: Helpful information for current residents
Nonsteroidal immunomodulator meets endpoints in cataract surgery postop inflammation trial
December 06, 2024 1 min read Key takeaways: More patients who received VVN461 achieved anterior chamber cell grade 0 compared with patients who received vehicle. The trial also met key secondary endpoints. A phase 2 clinical trial of VVN461, a nonsteroidal dual Janus kinase 1/tyrosine kinase 2 immunomodulator, met the primary … [Read more...] about Nonsteroidal immunomodulator meets endpoints in cataract surgery postop inflammation trial
BostonSight publishes pilot study on PROSE scleral lenses as a drug delivery system for cyclosporine in dry eye treatment
BostonSight announced the publication of a study titled Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study. The study was published in the journal Clinical Ophthalmology.¹Daniel Brocks, MD, Chief Medical Officer at BostonSight and lead investigator of the study, commented that the publication of … [Read more...] about BostonSight publishes pilot study on PROSE scleral lenses as a drug delivery system for cyclosporine in dry eye treatment
Phacovitrectomy vs. consecutive vitrectomy for idiopathic macular holes: short and long-term outcomes and OCT image quality assessment
Majumdar S, Tripathy K. Macular Hole. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Apr 30]. http://www.ncbi.nlm.nih.gov/books/NBK559200/Forsaa VA, Lindtjørn B, Kvaløy JT, Frøystein T, Krohn J. Epidemiology and morphology of full-thickness macular holes. Acta Ophthalmol. 2018;96:397–404.Article PubMed Google Scholar … [Read more...] about Phacovitrectomy vs. consecutive vitrectomy for idiopathic macular holes: short and long-term outcomes and OCT image quality assessment
Patient dosing underway in phase 3 LUCIA trial of Duravyu for wet AMD
December 05, 2024 1 min read The first patient underwent dosing in the phase 3 LUCIA clinical trial of Duravyu for wet age-related macular degeneration, according to a press release from EyePoint Pharmaceuticals. The LUCIA trial comes on the heels of the phase 3 LUGANO trial, which began dosing in October. Both are aflibercept-controlled noninferiority trials to assess … [Read more...] about Patient dosing underway in phase 3 LUCIA trial of Duravyu for wet AMD
VIDEO: Femtosecond laser for glaucoma shows good results out to 36 months
December 05, 2024 2 min watch CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Shawn O’Neil of ViaLase discusses the company’s femtosecond laser for incision-free primary open-angle glaucoma treatment. The laser, which is used for femtosecond laser image-guided high-precision trabeculotomy, showed positive safety and … [Read more...] about VIDEO: Femtosecond laser for glaucoma shows good results out to 36 months
Scott Hunter, chief commercial officer of Neurotech, dies
December 05, 2024 1 min read Neurotech Pharmaceuticals announced that chief commercial officer Scott Hunter died on Dec. 3. “The entire Neurotech family mourns this loss,” the company said in a statement. “On behalf of the board of directors, management team and employees, we extend our deepest sympathies to Scott’s family.” Scott Hunter joined Neurotech in … [Read more...] about Scott Hunter, chief commercial officer of Neurotech, dies